NEW MECHANISMS AND BIOMARKERS OF INHERITED NEUROPATHY

Description of the granted funding

Charcot-Marie-Tooth disease (CMT) is a hereditary disease that affects 1:2500 children and adults. CMT damages the nerves that transmit nerve impulses when we feel or move our hands or feet. Therefore, people with CMT have impaired sensation and muscle weakness, which lead to disability. So far, there is no cure for CMT. We recently found that one form of CMT is caused by mutation in a gene that handles calcium inside the cell. In this project, we will test how loss or mutation of genes that control the movement of calcium between different compartments of the cell affects the function of nerve cells. The experiments are based on cultured induced stem cells, which we can modify genetically and differentiate into nerve cells. In addition, we will investigate patients with CMT to find new markers in physical examination and blood tests, for diagnosis and follow up of CMT. Our results promise to advance the development of cures for CMT.
Show more

Starting year

2021

End year

2025

Granted funding

Emil Ylikallio Orcid -palvelun logo
248 483 €

Funder

Research Council of Finland

Funding instrument

Clinical researcher

Other information

Funding decision number

338875

Research fields

Kliiniset lääketieteet

Identified topics

brain, neuroscience